These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 25599953)
1. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus. Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953 [TBL] [Abstract][Full Text] [Related]
2. Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids. Liang W; Kwok PC; Chow MY; Tang P; Mason AJ; Chan HK; Lam JK Eur J Pharm Biopharm; 2014 Jan; 86(1):64-73. PubMed ID: 23702276 [TBL] [Abstract][Full Text] [Related]
3. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis. Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107 [TBL] [Abstract][Full Text] [Related]
4. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537 [TBL] [Abstract][Full Text] [Related]
5. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597 [TBL] [Abstract][Full Text] [Related]
6. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders. Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763 [TBL] [Abstract][Full Text] [Related]
8. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity. Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404 [TBL] [Abstract][Full Text] [Related]
9. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations. Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971 [TBL] [Abstract][Full Text] [Related]
10. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin. Chow MYT; Qiu Y; Liao Q; Kwok PCL; Chow SF; Chan HK; Lam JKW Int J Pharm; 2019 Dec; 572():118818. PubMed ID: 31678379 [TBL] [Abstract][Full Text] [Related]
11. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections. Saha T; Lyons N; Yue Yung DB; Quiñones-Mateu ME; Pletzer D; Das SC Eur J Pharm Biopharm; 2024 Feb; 195():114170. PubMed ID: 38128743 [TBL] [Abstract][Full Text] [Related]
12. Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique. Okuda T; Kito D; Oiwa A; Fukushima M; Hira D; Okamoto H Biol Pharm Bull; 2013; 36(7):1183-91. PubMed ID: 23811567 [TBL] [Abstract][Full Text] [Related]
13. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections. Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745 [TBL] [Abstract][Full Text] [Related]
15. Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung. Ito T; Okuda T; Takayama R; Okamoto H J Pharm Sci; 2019 Aug; 108(8):2661-2667. PubMed ID: 30954524 [TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X; Vogt FG; Hayes D; Mansour HM Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736 [TBL] [Abstract][Full Text] [Related]
17. Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation. Chow MY; Lam JK Curr Pharm Des; 2015; 21(27):3854-66. PubMed ID: 26290202 [TBL] [Abstract][Full Text] [Related]
18. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657 [TBL] [Abstract][Full Text] [Related]
19. Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying. Agnoletti M; Bohr A; Thanki K; Wan F; Zeng X; Boetker JP; Yang M; Foged C Eur J Pharm Biopharm; 2017 Nov; 120():9-21. PubMed ID: 28780275 [TBL] [Abstract][Full Text] [Related]
20. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]